Cardiac Valve Market is Expected to Grow at a CAGR of 10.80% by 2030

Pune, India, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global cardiac valve market.

Market Highlights

Human heart is consist of four valve. When blood first enters the heart, it passes through the tricuspid valve and then the pulmonary valve. After returning from the lungs, the blood passes through the mitral valve and exits via the aortic valve as heart valves are one-way valves. 

Furthermore, valve replacement remains the most widely used technique and the proportion of valve repair procedures is increasing in experienced treatment centers. Moreover, increasing development in medical technology and its wide range of application used in the treatment of various cardiac diseases will fuel the growth of the market.

However, high cost of the treatment likely to restrain the growth of the market over the assessment period.

The Cardiac Valve Market is expected to reach USD 6,800 Million by 2030 at 10.80% CAGR during the forecast period 2022-2030.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “cardiac valve market research report–Global forecast till 2030.”

Major Players in Cardiac Valve Market

Some of the key players in the global market are Medtronic, Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK HealthCare (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) 

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Cardiac Valve Market Research Report

Regional Analysis

The global cardiac valve market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global cardiac valve market. North America is the largest market owing to rising prevalence of cardiovascular patient population in the American counties and well-developed technology in this region.

Europe accounts for the second largest share of the global cardiac valve market. In Europe, huge demand for new treatment methods for vulvar heart diseases drives the market growth. Moreover, increasing expenditure in healthcare domain and investment in research & development in developing new treatment methods for various cardiac diseases will fuel to the growth of the market.  

Asia Pacific is the fastest growing market in the world. India is the largest potential market due to increasing investments in the healthcare services and increasing adaption of new technologies in diagnosis and treatment methods.  

The Middle East & Africa is expected to witness low market share due to less technological development in healthcare domain.

Segmentation

The global cardiac valve market is segmented on the basis of types, by diseases, by treatment, and by end users.

On the basis of types, the market is segmented into trans-catheter heart valve, tissue heart valve, mechanical heart valve, and others.

On the basis of disease, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, and others.

On the basis of treatments, it is segmented into valve replacement, valve repair, and others.

On the basis of end users the market is segmented into cardiac research institute, hospital & clinics, and others.